LY2624803

DRUG3 trials

Sponsors

Eli Lilly and Company

Conditions

InsomniaPrimary InsomniaSecondary Insomnia

Phase 1

Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject

CompletedNCT01236105

Eli Lilly and CompanyInsomnia

Start: 2010-10-31End: 2010-12-31Updated: 2011-12-22

A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic Impairment

TerminatedNCT01257178

Eli Lilly and CompanyInsomnia

Start: 2010-11-30End: 2010-11-30Updated: 2011-06-03

Phase 2

An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia

CompletedNCT00784875

Eli Lilly and CompanyPrimary Insomnia, Secondary Insomnia

Start: 2008-10-31End: 2010-02-28Updated: 2012-02-29